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SUMMARY
We leverage the SM/J mouse to understand glycemic control in obesity. High-fat-fed SM/J mice initially
develop poor glucose homeostasis relative to controls. Strikingly, their glycemic dysfunction resolves by
30 weeks of age despite persistent obesity. The mice dramatically expand their brown adipose depots as
they resolve glycemic dysfunction. This occurs naturally and spontaneously on a high-fat diet, with no temper-
ature or genetic manipulation. Removal of the brown adipose depot impairs insulin sensitivity, indicating that
the expanded tissue is functioning as an insulin-stimulated glucose sink. We describe morphological, physio-
logical, and transcriptomic changes that occur during the brown adipose expansion and remission of glycemic
dysfunction, and focus on Sfrp1 (secreted frizzled-related protein 1) as a compelling candidate thatmay under-
lie this phenomenon. Understanding how the expanded brown adipose contributes to glycemic control in SM/J
mice will open the door for innovative therapies aimed at improving metabolic complications in obesity.
INTRODUCTION
An estimated 10%–30% of obese individuals maintain glycemic
control, and some longitudinal studies suggest their risk of devel-
oping type II diabetes is no greater than matched lean individuals
(Meigs et al., 2006). Nocausative factors underlying glycemic con-
trol in obesity have been discovered; however, the strongest pre-
dictors of impaired glycemic control in obesity are increased
visceral fat mass and adipose tissue dysfunction (Goossens,
2017; Klöting et al., 2010). Thus, research efforts have focused
on understanding the genetic and physiological mechanisms of
actionof adipose.Recent research reveals that brownadipose ac-
tivity is associated with anti-diabetic properties. Cold exposure in
both obese and lean individuals causes increased uptake of fatty
acids and glucose into brown adipose tissue (Saito et al., 2009).
Further, increased brown adipose activity has been shown to
improve glucose homeostasis and insulin sensitivity in adults
(Chondronikola et al., 2014). Transplantation of brown adipose tis-
sue into mouse models of diabetes greatly improves glucose pa-
rameters, including fasting glucose levels and response to a
glucose challenge (Gunawardana and Piston, 2012). Although
there are a variety of obese and diabetic mouse models, there
are no mouse models for understanding the relationship between
brown adipose and glycemic control in obesity.
The SM/J inbred mouse strain has long been used for studying
interactions between diet andmetabolism, andmore recently has
started to help uncover the genetic architecture underlying diet-
induced obesity and glucose homeostasis. It has previously
been shown that fed a high-fat diet, SM/J mice display many of
the characteristics of a diabetic-obese mouse: obesity, hypergly-
cemia, and glucose intolerance at 20 weeks of age (Cheverud
et al., 2011; Ehrich et al., 2003; Lawson et al., 2010, 2011). We
discovered that SM/J mice undergo a remarkable transformation
between 20 and 30 weeks of age. Despite persistence of the
obese state, these mice enter into diabetic remission: returning
to normoglycemia and reestablishing glucose tolerance and
improving insulin sensitivity. Contemporary with this remission
of glycemic parameters is a dramatic expansion of the intrascap-
ular brown adipose depot. Our results strongly suggest that SM/
J’s brown adipose contributes to their diabetic remission through
non-thermogenic mechanisms, and we focus on the cytokine
Secreted Frizzled-Related Protein 1 (SFRP1) as a compelling
candidate that may underlie this remarkable phenomenon. This
study describes the morphological, physiological, and transcrip-
tomic changes that occur during this transition, and establishes
the SM/Jmouse as a uniquemodel for understanding the relation-
ship between brown adipose and glycemic control in obesity.
Understanding this relationship in a genetic model of glycemic
resolution will set the stage for identifying novel, potentially thera-
peutic targets for the improvement of glycemic control.
RESULTS
SM/JMice Improve Glucose Parameters without Weight
Loss
When fed a high-fat diet (Table S1) from 3 weeks of age, SM/J
mice develop obesity, hyperglycemia, and impaired glucose
tolerance by 20 weeks (Ehrich et al., 2003). By 30 weeks, despite
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the persistence of obesity, high-fat-fed SM/J mice resolve their
hyperglycemia and impaired glucose tolerance to levels indistin-
guishable from low-fat-fed controls (Figures 1A–1D). Thirty-week
high-fat-fed SM/J mice have dramatically increased serum and
pancreatic insulin levels compared with 20-week animals
(Miranda et al., 2020), and insulin sensitivity improves along
with improved glycemic parameters (Figures 1E and 1F).
Notably, metabolic hormones, such as adiponectin, glucagon,
IGF1, and leptin, do not show any changes in circulating levels
between 20 and 30 weeks (Figures S1A–S1D). Further, the
changes in glucose phenotypes are not transient effects; rather,
high-fat-fed animals maintain improved basal glucose, glucose
tolerance, and insulin tolerance as they age (Figures S1E–S1I).
High-fat-fed C57BL/6J mice also show a reduction in fasting
glucose that is accompanied by increased insulin with age (Win-
zell and Ahrén, 2004). In contrast with SM/J, the difference in
circulating glucose between the high-fat- and low-fat-fed
C57BL/6J mice remains significantly different over time. More-
over, high-fat-fed C57BL/6J mice show marked glucose intoler-
ance that does not resolve with age. We observe a similar trend
in the LG/J strain of mice, where high-fat-fed animals maintain
higher fasting glucose levels and impaired glucose tolerance rela-
Figure 1. Obese SM/J Mice Improve Glucose
Parameters between 20 and 30Weeks of Age
(A) High-fat-fed mice weigh significantly more than
low-fat-fed mice, and SM/J mice gain weight be-
tween 20 and 30 weeks of age on both diets; n =
140, 106, 78, and 48 mice in high-fat-fed 20, high-
fat-fed 30, low-fat-fed 20, and low-fat-fed 30 co-
horts.
(B) 30-week-old high-fat-fed mice have significantly
lower fasting glucose levels than at 20 weeks.
(C and D) 30-week-old high-fat-fed mice have
improved glucose tolerance relative to 20 weeks.
(E and F) Lower fasting glucose and improved
glucose tolerance correspond with improved insulin
sensitivity.
Equal numbers of males and females are repre-
sented; n = 39–49 mice per 30-week cohort; n = 51–
71 mice per 20-week cohort. The boxplots display
median, 1st and 3rd quartiles, and 1.53 interquartile
range for each cohort. Individual data points are
also represented. *p < 0.05, **p < 0.01, ***p < 0.001.
See also Figure S1.
tive to low-fat-fed controls as they age (Fig-
ures S1J and S1L–S1P). The unique remis-
sion of hyperglycemia and improved
glucose tolerance observed in the high-
fat-fed SM/J strain indicate a genetic basis.
High-Fat-Fed SM/J Mice Expand
Their Interscapular Brown Adipose
Tissue Depots
Contemporary with the resolution of glyce-
mic parameters, high-fat-fed SM/J mice
dramatically expand their intrascapular
brown adipose depots, which is not seen
in low-fat-fed control mice (Figures 2A–
2C). This has never been described in
another mouse strain, and we do not observe the phenomenon
in the LG/J strain of mice on the same diets at any age (Fig-
ure S1K). To understand whether the tissue mass expansion is
due to increased size of individual cells or to increased number
of total cells, we quantified adipocyte cell size and the mitotic in-
dex. There are no significant differences in average cell size in
high-fat-fed mice between 20 and 30 weeks or relative to low-
fat-fed controls (Figure S2A). Mice on both diets undergo altered
adipocyte area profiles between 20 and 30 weeks of age; howev-
er, the low-fat tissue develops a profile significantly trending to-
ward larger adipocytes at 30 weeks (p = 6.4e7), whereas the
high-fat tissue develops a profile significantly trending toward
smaller adipocytes at 30 weeks (p = 2.2e16) (Figures 2D and
2E). This suggests that the expansion of the brown adipose depot
in high-fat-fed mice is not the result of increased lipid uptake into
already existing adipocytes. Quantification of brown adipose cells
stained positive for the mitotic marker phosphohistone H3
showed a trend toward a higher mitotic index in the brown adi-
pose of high-fat-fed animals (Figure S2B), suggesting that the
increased mass may be caused by an increased number of cells.
Because obesity has been associated with structural and
functional ‘‘whitening’’ of brown adipose depots in rodents
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(Lapa et al., 2017; Roberts-Toler et al., 2015; Shimizu andWalsh,
2015; Shimizu et al., 2014), we confirmed that the tissue expan-
sion in SM/J mice has the expected properties of brown fat. His-
tological analysis of the fat depot taken from high-fat-fed SM/J
mice at 30 weeks of age confirms the adipocytes in this expan-
sion are brown adipocytes, with small multilocular lipid droplets
and high UCP1 staining (Figures S2C–S2J). Expression of ca-
nonical brown adipose genes (Ucp1, Cidea, Eva1, Prdm16,
Pgc1a) does not change between 20 and 30 weeks (Figures
S2L–S2P), nor is there any evidence of a general ‘‘beiging’’ phe-
nomenon in white adipose tissue (Wu et al., 2012). There is no
significant difference in brown adipose tissue mitochondrial
Figure 2. Brown Adipose Expansion in 30-Week-Old High-Fat-Fed SM/J Mice Is Required for Improved Insulin Tolerance
(A and B) Representative pictures of (A) 20- and (B) 30-week-old high-fat-fed female mice with insets showing larger brown adipose lobes in 30-week animals.
(C) Quantification of interscapular brown adipose depot as a proportion of total fat mass; n = 16–25 mice per cohort.
(D and E) Cell area density graphs for high-fat- and low-fat-fed cohorts. Data are plotted on a log10 scale for visualization; n = 4 mice per cohort.
(F–H) Fasting glucose (F) and insulin (G) and glucose (H) tolerance were not significantly altered by removal of the brown adipose depot before (20-week excision)
or after (30-week excision) expansion.
(I) Insulin tolerance was significantly worse after brown adipose tissue (BAT) ablation; n = 8 mice per excision cohort.
(J and K) Expression of (J) Irs1 and (K) Glut4 increases significantly in expanded brown adipose depot; n = 8 mice per cohort.
Equal numbers of males and females are represented. The boxplots display median, 1st and 3rd quartiles, and 1.5 3 interquartile range for each cohort. Line
graphs were generated using loess regression and smoothing. Individual data points are also represented. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S2.
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content (Figure S2K), core body temperature, or circulating free
fatty acids between high- and low-fat-fed cohorts or between 20
and 30 weeks of age (Figures S2U and S2V). Additionally,
although there are diet-dependent differences in the catechol-
amines norepinephrine and epinephrine, which activate UCP1-
mediated leak respiration and non-shivering thermogenesis,
there is no change in levels between ages in the high-fat-fed
mice (Figures S2W and S2X). Thus, the interscapular adipose
depot in high-fat-fed SM/J mice maintains a brown adipose
identity after expansion that is not dependent on whole-animal
beiging and is also not associated with altered thermogenesis.
Expanded Brown Adipose Tissue Serves as an Insulin-
Stimulated Glucose Sink
If the brown adipose expansion is directly related to the glycemic
resolution of the high-fat-fed SM/J mice, preventing or removing
that expansion should revert their glucose parameters to an un-
healthy state. To test these predictions, we removed the inter-
scapular brown adipose depots from hyperglycemic 20-week-
old andnormoglycemic 30-week-oldmice. Interestingly, removal
of the brown adipose depot at 20 weeks does not affect serum
glucose or insulin levels, or the glucose tolerance of the animals,
indicating that theexpandedbrownadipose isdownstreamof the
primary signal (Figures 2F–2H) (Miranda et al., 2020). However,
removal of the brown adipose depot before expansion prevents
the natural improvement in insulin tolerance, and removal of the
expanded tissue at 30 weeks results in a reversion to 20-week-
old measurements (Figure 2I). These results strongly suggest
that the expanding brown adipose tissue of obese SM/J mice
serves as an insulin-stimulated glucose sink. This is supported
by increased expression of both Irs1 and Glut4 (Figures 2J and
Figure 3. High-Fat-Fed SM/J Mice Have
Unique Brown Adipose Differential Expres-
sion between 20 and 30 Weeks of Age
(A) Venn diagram illustrating the number of genes
differentially expressed between high- and low-fat-
fed 20- and 30-week-old SM/J interscapular brown
or reproductive white adipose tissues.
(B) Terms enriched in genes differentially expressed
by age in high-fat SM/J brown adipose colored by
class: Gene Ontology Biological Process (GO_BP),
Cellular Component (GO_CC), Molecular Function
(GO_MF), and Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathway.
(C) Heatmap of differentially expressed brown adi-
pose tissue genes belonging to cytokine, extracel-
lular matrix, or both gene ontologies.
See also Tables S2 and S3.
2K), key members of the insulin-stimulated
glucosepathway (Pessin andSaltiel, 2000).
RNA Sequencing Reveals
Enrichment of Differentially
Expressed Cytokines and Genes
Affecting Extracellular Matrix
Because the brown adipose tissue expan-
sion is unique to high-fat-fed SM/J mice,
we anticipated that there would be corresponding unique tran-
scriptomic changes in the brown adipose. Indeed, we identified
267 genes whose expression significantly and uniquely changes
between 20 and 30 weeks of age in high-fat-fed SM/J brown ad-
ipose tissue (at a 5% false discovery rate [FDR], out of 13,253 to-
tal genes expressed; Table S2). These expression changes
occur when the mice resolve their glycemic dysfunction and
expand their brown adipose depots. These genes are not differ-
entially expressed in white adipose tissue taken from the same
animals or in low-fat-fed SM/J controls (Figure 3A). Additionally,
they are not differentially expressed in the LG/J strain of mouse,
once again underscoring the genetic basis of the phenomenon
(Table S3).
Over-representation analysis indicates these genes are en-
riched for those involved in cytokine-cytokine receptor interac-
tions (p = 3.23e6), signaling receptor activity (p = 5.70e6),
cell surface receptor signaling (p = 2.04e7), and extracellular
matrix (ECM) components (p = 7.93e13) (Figure 3B). Several
genes belonging to these biological categories have evidence
for their involvement in glucose homeostasis and change
expression in a direction that is associated with improved meta-
bolic health in high-fat-fed SM/J mice between 20 and 30 weeks
of age (Figure 3C; Table S2). These are intriguing results because
brown adipose has been identified as a source of cytokines that
influences glucose homeostasis, and extracellular matrix
changes are essential for tissue expansion, cellular signaling,
and regulation of growth factor bioavailability (Lin and Farmer,
2016; Wang et al., 2015). However, extreme changes in ECM
protein levels are associated with adipose dysfunction in
obesity; thus, a fine balance between tissue remodeling and
excessive accumulation of ECM proteins must be achieved to
4 Cell Reports 33, 108237, October 6, 2020
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maintain adipose tissue homeostasis (Sun et al., 2013). The di-
rection of expression change in high-fat-fed SM/J mice reveals
that their brown adipose expansion is associated with
decreased expression of inflammatory (e.g., interleukin-7 recep-
tor [Il7r]) (Kim et al., 2014) and fibrotic markers (e.g., collagen
type VIII alpha 1 chain [Col8a1], semaphorin 3C [Sema3c]) (Mej-
hert et al., 2013; Sun et al., 2013), and changes in extracellular
matrix components (e.g., matrix metallopeptidase 12 [Mmp12],
procollagen c-endopeptidase enhancer [Pcolce]) (Huang et al.,
2011; Lee et al., 2014) and cytokines (e.g., coagulation factor
VII [F7], leptin [Lep], Sfrp1) (D’souza et al., 2017; Edén et al.,
2015; Gauger et al., 2013) associated with metabolic health.
Other mouse models of diet-induced obesity develop unhealthy
brown adipose transcriptomes characterized by increased
expression of pro-inflammatory genes and fibrotic markers (Al-
calá et al., 2017). The direction of expression change in SM/J
brown adipose tissue supports the uniqueness of this mouse
model.
Increased Sfrp1 Expression in ExpandedBrownAdipose
Tissue Correlates with Improved Glucose Tolerance
We focused on Sfrp1 as a candidate gene that may underlie the
increased brown adipose mass in SM/J high-fat-fed mice. Sfrp1
is a cytokine that inhibits Wnt/b-catenin signaling. Wnt/b-catenin
signaling promotes the fibroblast identity, and Sfrp1 blocks Wnt
signaling to promote adipogenesis (Gauger et al., 2013; Lagathu
et al., 2010; Wang et al., 2018). Its expression significantly in-
creases in high-fat-fed SM/J brown adipose between 20 and
30 weeks, when the mice increase the size of their brown adi-
pose depots and enter diabetic remission, and does not increase
in white adipose of these same animals, or in the white or brown
adipose of LG/J mice (Figures 4A and 4B; Figures S3A and S3B).
Further, Sfrp1 expression significantly correlates with brown ad-
ipose depot mass and with improved glucose tolerance in high-
fat-fed SM/J mice (Figures 4C and 4D). We performedmediation
analysis and found that the effects of Sfrp1 expression on
glucose tolerance in high-fat-fed SM/Jmice is significantly medi-
ated by brown adipose mass (p = 0.004). Data from a human
genome-wide association study (GWAS) revealed several vari-
ants in the SFRP1 locus, including one variant (rs973441) that
is significantly associated with type 2 diabetes adjusted for
body mass index (BMI) (Figure 4E) (Mahajan et al., 2018). There
are several variants in the Sfrp1 locus between SM/J and LG/J
genetic backgrounds, and the gene is located within the support
intervals of QTL associated with adiposity and glucose tolerance
that weremapped in an F16 LG3 SM intercross (Figure 4F) (Law-
son et al., 2010, 2011). These data further underscore that the
SM/J genetic background has unique variants that contribute
to its brown adipose expansion and diabetic remission. We hy-
pothesize that DNA variants in SM/J mice increase Sfrp1, which
in turn promotes brown adipogenesis by inhibiting Wnt/b-cate-
nin signaling, and this in turn may contribute to the tissue’s role
as a glucose sink (Figure 4G).
DISCUSSION
Brown adipose has anti-diabetic properties that are conserved
between mice and humans (Chechi et al., 2013; Cypess et al.,
2009; Hanssen et al., 2016; van Marken Lichtenbelt et al.,
2009; Saito, 2013; Saito et al., 2009; Stanford et al., 2013; Virta-
nen et al., 2009). Most brown adipose tissue research focuses on
the effects of non-shivering thermogenesis on metabolic health.
However, brown adipose coordinates a diverse array of physio-
logical processes through the action of secreted factors associ-
ated with glucose homeostasis (e.g., fibroblast growth factor 21
[FGF21], bonemorphogenic proteins [BMPs], Vascular endothe-
lial growth factor A [VEGFA], interleukin 6 [IL-6], neuregulin 4
[NRG4]) (Poekes et al., 2015; Villarroya et al., 2017, 2019; Kaji-
mura et al., 2015). Further, the mechanism of insulin-stimulated
glucose uptake into brown adipose tissue was well established
before the discovery of beta-adrenergic stimulation of thermo-
genesis (Marette and Bukowiecki, 1989). This mechanism is in-
dependent of UCP1 activity (Inokuma et al., 2005; Olsen et al.,
2019; Orava et al., 2011). Insulin-stimulated glucose uptake in-
creases in animals with brown adipose transplants (Stanford
et al., 2013) and is blunted under obese (Orava et al., 2013)
and diabetic conditions (Lapa et al., 2017). Here we report a nat-
ural expansion of brown adipose tissue in obese mice that coin-
cides not with increased thermogenesis, but with improved insu-
lin sensitivity, likely through increased insulin-stimulated glucose
uptake into the brown adipose tissue. We have shown corre-
sponding increased expression of two critical members of the in-
sulin signaling pathway: Glut4, which mediates insulin-stimu-
lated, but not norepinephrine-stimulated, glucose uptake
(Shimizu et al., 1996), and Irs1, which is also necessary for brown
adipose differentiation (Fasshauer et al., 2001). It is possible that
brown adipose expansion in high-fat-fed SM/J mice is a protec-
tive mechanism to improve insulin sensitivity before the hyper-
glycemia gets out of control.
We found that genes associated with cytokine activity are en-
riched in the expanded tissue and diabetic remission. Cytokine
secretion likely contributes to the obesity-independent ability
of SM/J’s brown adipose tissue to affect systemic glucosemeta-
bolism (Matsushita et al., 2014; Samms et al., 2015).We highlight
Sfrp1 as a particularly intriguing cytokine that may underlie this
phenomenon. Sfrp1 inhibits Wnt signaling, thus promoting adi-
pogenesis (Ackers and Malgor, 2018; Bennett et al., 2002; Laga-
thu et al., 2010). Expression of Sfrp1 increases as adipocytes
differentiate, proportional to the strength of adipogenic stimula-
tion, and also increases during treatment with thiazolidinedione
drugs, which generally act through improving insulin-mediated
glucose metabolism (Lagathu et al., 2009). Although Sfrp1 has
never been directly studied in brown adipose tissue, it is a mem-
ber of a brown adipose coexpression module of genes enriched
for cell division, with its expression strongly correlated with
brown adipose mass in particular (Carson and Lawson, 2020).
In human obesity, SFRP1 expression is downregulated in sub-
cutaneous white adipose tissue, correlating with impaired insulin
sensitivity (Ehrlund et al., 2013). Further, its expression was
found to be deficient in obese patients with glycemic dysfunction
(Chen and Wang, 2018; Ehrlund et al., 2013; Lagathu et al.,
2010). Finally, high-fat-fed Sfrp1/ mice show dysregulation
of glucose metabolism, including downregulation of Glut4 in
white adipose tissue (Gauger et al., 2013). We show increased
Sfrp1 expression in an expanding brown adipose depot that cor-
responds with increased Glut4 expression underlying potential
Cell Reports 33, 108237, October 6, 2020 5
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Figure 4. Increased Expression of Sfrp1 Is Likely
Culprit of Brown Adipose Tissue Expansion
(A and B) Expression of Sfrp1 increases in (A) brown, but
not (B) white, adipose tissue of high-fat-fed animals.
(C and D) Sfrp1 expression correlates with brown adipose
mass across cohorts (C) and with improved glucose
tolerance in high-fat-fed SM/J mice (D).
(E) Screenshot of variants in human adipose tissue in the
SFRP1 locus region. Rs973441 is significantly linked with
type 2 diabetes adjusted for BMI.
(F) The Sfrp1 locus region contains multiple variants be-
tween SM/J and LG/J strains and is located in the
quantitative trait locus (QTL) associated with adipose
weight and glucose tolerance mapped in an F16 inter-
cross of the strains.
(G) Model of Sfrp1 acting to increase brown adipo-
genesis. Sfrp1 sequesters Wnt away from its receptor,
leading to phosphorylation and degradation of beta-cat-
enin and thus allowing an adipogenic transcriptional
program. The boxplots display median, 1st and 3rd quar-
tiles, and 1.5 3 interquartile range for each cohort. Indi-
vidual data points are also represented. Equal numbers of
males and females are represented; n = 8–17 mice per
cohort. *p < 0.05, **p < 0.01, ***p < 0.001.
See also Figure S3.
6 Cell Reports 33, 108237, October 6, 2020
Report
ll
OPEN ACCESS
improvement in insulin-stimulated glucose uptake. Although
previous studies of Sfrp1 have been conducted only in white ad-
ipose tissue, the data we present fit a model where brown adipo-
cyte-secreted SFRP1 may act in an autocrine manner to stimu-
late brown adipose proliferation, leading to its role as an
insulin-stimulated glucose sink and resulting in improved
glucose tolerance and insulin sensitivity.
There is great interest in harnessing the potential of brown ad-
ipose to treat obesity and diabetes, either through the calorie-
burning action of non-shivering thermogenesis or the endocrine
action of adipokines. Research into the effects of brown adipose
on systemic metabolism is in its infancy, and the community
needs appropriate animal models to interrogate its physiological
roles and identify potentially druggable targets. We present the
SM/J mouse strain as a unique model to address this need. The
SM/Jmouse provides a tractable, genetic system in which to un-
derstand the relationship between brown adipose and glycemic
control in obesity. Understanding this relationship in the SM/J
mousewill open doors for identifying novel, potentially druggable
targets for the improvement of glycemic control in humans.
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Materials Availability
This study did not generate new unique reagents.
Data and Code Availability
RNA-sequencing data generated for this study have been deposited at the Gene Expression Omnibus GSE157569 (https://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE157569).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
SM/J (RRID:IMSR_JAX:000687) and LG/J (RRID:IMSR_JAX:000675) mice were obtained from The Jackson Laboratory (Bar Harbor,
ME). Experimental animals were generated at the Washington University School of Medicine and all experiments were approved by
the Institutional Animal Care and Use Committee in accordance with the National Institutes of Health guidelines for the care and use
of laboratory animals. Pups were weaned at 3 weeks and reared in same-sex cages of 3-5 animals until necropsy. At weaning, mice
were randomly placed on a high fat diet (42% kcal from fat; Teklad TD88137) or an isocaloric low fat diet (15% kcal from fat; Research
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
rabbit anti-Ucp1 Sigma Cat#U6382; RRID: AB_261838
mouse anti-pHH3 Invitrogen Cat#MA5-15220; RRID: AB_11008586
donkey anti-rabbit 488 Abcam Cat#ab150061; RRID: AB_2571722
donkey anti-mouse 647 Abcam Cat#ab150107
hematoxylin Leica Surgipath Cat#3801570
eosin Leica Surgipath Cat#3801616
Critical Commercial Assays
Free Fatty Acids ELISA Wako Life Sciences Cat#995-34693
Leptin ELISA Crystal Chem Cat#90030; RRID AB_2722664
Adiponectin ELISA Crystal Chem Cat#80569
IGF1 ELISA Crystal Chem Cat#80574
Glucagon ELISA Crystal Chem Cat#81518; RRID AB_2811007
Deposited Data
RNA-sequencing data for brown and white
adipose tissue
https://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE157569
GSE157569
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Software and Algorithms
STAR Dobin et al., 2013 N/A
edgeR Chen et al., 2014 N/A
WEBGestalt Zhang et al., 2005 N/A
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Diets D12284) (Table S1). Feeding was ad libitum. The animal facility operates on a 12 hour light/dark cycle with a constant ambient
temperature of 21C. All experiments were performed during the light phase. Mice of both sexes were used for all experiments. Age
information for experimental animals can be found in each figure or table legend.
METHOD DETAILS
Phenotyping
Animals were weighedweekly until sacrifice. At 8, 18, 28, 38, and 48weeks of age, animals were fasted for four hours (starting at 9am)
before an intraperitoneal glucose tolerance test (starting at 1pm). At 19, 29, 39, and 49 weeks of age animals were subject to an intra-
peritoneal insulin tolerance test. At 10, 20, 30, 40, or 50 weeks of age, body composition was determined byMRI for SM/Jmice. Body
temperature of animals at 20 and 30 weeks of age was determined using a rectal thermometer. All animals were fasted for four hours,
then given an overdose of sodium pentobarbital. Once the animals were anesthetized, blood was collected via cardiac puncture and
euthanasia was achieved by cardiac perfusion with phosphate-buffered saline. After cardiac perfusion, tissues were collected and
flash frozen in liquid nitrogen and stored at 80C, or processed according to protocols for histology and other assays.
Blood plasma assays
Fasting blood glucose was measured using a GLUCOCARD Vital glucometer (Arkay, MN USA). ELISAs measuring plasma levels of
free fatty acids (Wako Life Sciences 995-34693), leptin (Crystal Chem #90030), adiponectin (Crystal Chem #80569), IGF1 (Crystal
Chem #80574), and glucagon (Crystal Chem #81518) were quantified according to manufacturer’s protocol. Catecholamines
were assayed through the Vanderbilt University Medical Center’s Hormone Assay and Analytical Services Core (https://www.
vumc.org/hormone/assays; NIH grants DK059637 (MMPC) and DK020593 (DRTC)).
Adipose histology
At the time of tissue collection, small portions of interscapular brown and reproductive white adipose tissues were placed in 1 mL of
neutral buffered formalin. These samples were incubated at 4C while gently shaking for 24 hours. Immediately afterward, samples
were placed into plastic cages and processed into paraffin blocks using a Leica tissue processor with the following protocol: 70%
EtOH for 1 hour x 2, 85% EtOH for 1 hour, 95% EtOH for 1 hour x 2, 100% EtOH for 1 hour x 2, Xylenes for 1 hour x 2, paraffin wax.
Adipose blocks were sectioned into 6 mm sections, with 2-4 slices on each slide.
H&E Staining
Slides were incubated at 60C for 1 hour, then placed in xylenes to remove remaining paraffin wax. Slides were then rehydrated using
successive decreasing EtOH concentrations (xylenes x 2, 100% EtOH x 2, 95% EtOH, 70% EtOH, H2O). Slides were incubated in
hematoxylin (Leica Surgipath 3801570), Define (3803590), Blue Buffer 8 (3802915), and eosin (3801616), and dehydrated (95%EtOH,
100%EtOH, xylene x 2). Imagingwas performed using the Zeiss AxioPlan2microscope andOlympusDP software. Analysis of adipo-
cyte size was performed using ImageJ. Images were converted to black and white and skeletonized to reveal only the cell wall out-
lines. Cell area was calculated from outlines with a lower limit of 50 um and upper limit of 700 um to reduce noise. All cells from a
cohort (4-7 images each from 4 animals per cohort, equal numbers of males and females) were pooled for cell area density analysis.
Immunofluorescence
Slides were incubated at 60C for 1 hour, then placed in xylenes to remove remaining paraffin wax. Slides were then rehydrated using
successive decreasing EtOH concentrations (xylenes x 2, 50% EtOH in xylenes, 100% EtOH x 2, 95% EtOH, 70% EtOH, 50% EtOH,
0.3% H2O2 in MeOH, H2O). Slides were washed with TBS and blocked in 10% normal donkey serum (Abcam ab7475) for 1 hour,
followed by incubation with primary antibody overnight at 4C. [Primary antibodies: rabbit anti-Ucp1 (1:100, Sigma U6382) and
mouse anti-PHH3 (1:100, Invitrogen MA5-15220)]. After an additional wash, secondary antibody was applied for 1 hour at room tem-
perature [Secondary antibodies: donkey anti-rabbit 488 (1:1000, Abcam ab150061) and donkey anti-mouse 647 (1:200, Abcam
ab150107)]. Fluoroshield Mounting Medium with DAPI (Abcam) was applied to seal the coverslip and slides were stored at 4C. Im-
aging was performed using the Zeiss Confocal microscope and Zen Lite imaging program. PHH3 analysis was performed using the
CellProfiler program. Background was subtracted from DAPI and PHH3 channels using ImageJ. DAPI channel was used to identify
total nuclei in CellProfiler. Adipose nuclei images were overlaid with PHH3 stain to identify mitotic adipose nuclei. Mitotic nuclei were
summed across all 4 slides for each individual. Mitotic adipose index is reported as mitotic adipose nuclei divided by adipose nuclei
multiplied by 100%.
Quantitative rt-PCR
Total RNA was extracted from brown, subcutaneous inguinal, and visceral reproductive adipose samples using the QIAGEN RNeasy
Lipid Kit. High-Capacity cDNA Reverse Transcription Kit (Thermofisher) was used for reverse transcription. Quantitative-rtPCR was
performed to assess expression levels of target genes with an Applied Biosystems (USA) QuantStudio 6 Flex instrument using SYBR
Green reagent. Results were normalized to L32 expression, which was experimentally determined to not be differentially expressed
across diet and age cohorts. cDNA products were analyzed by the DCT method. Primers: L32 forward TCCACAATGTCAAGG
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AGCTG, reverse GGGATTGGTGACTCTGATGG; Adipoq forward ACGTCATCTTCGGCATGACT, reverse CTCTAAAGATTGTCA
GTCCATCTG ; Cidea forward TGCTCTTCTGTATCGCCCAGT, reverse GCCGTGTTAAGGAATCTGCTG; Eva1 forward
CCACTTCTCCTGAGTTTACAGC reverse GCATTTTAACCGAACATCTGTCC; Fabp4 forward CACTTTCCTTGTGGCAAAGC, reverse
AATGTGTGATGCCTTTGTGG ; Pparg forward GAATGCGAGTGGTCTTCCAT, reverse TGCACTGCCTATGAGCACTT; Prdm16 for-
ward CCACCAGCGAGGACTTCAC reverse GGAGGACTCTCGTAGCTCGAA; Sfrp1 forward TACTGGCCCGAGATGCTCAA, reverse
GAGGCTTCCGTGGTATTGGG; Tbx1 forwardGGCAGGCAGACGAATGTTC, reverse TTGTCATCTACGGGCACAAAG;Ucp1 forward
CCTCTCCAGTGGATGTGGTAA, reverse AGAAGCCACAAACCCTTTGA.
Mitochondrial DNA quantification
DNA was extracted from brown and inguinal adipose tissues using the QIAGEN DNeasy Blood and Tissue Kit. Briefly, 40mg of tissue
was homogenized in 10% proteinase K through vortexing and incubation at 56C. DNA was precipitated with ethanol, collected in a
spin column, and eluted in 150mL of buffer. DNA concentration was quantified on aNanodrop, and 50ngwas used in a qPCR reaction
to quantify the amount of h19 (nuclear gene) and CytB (mitochondrial gene). Mitochondrial content was calculated as the ratio of
mtDNA to nucDNA. Primers used: Cytb forward TCTACGCTCAATCCCCAATAAAC, reverse TTAGGCTTCGTTGCTTTGAGGT; h19
forward TATGTGCCATTCTGCTGCGA, reverse AAGGTTTAGAGAGGGGGCCT.
RNA sequencing and analyses
Sixty-four LG/J and SM/J mice were used for sequencing analysis, representing 4 males and 4 females from each diet (high and low
fat) and age (20 and 30 weeks). Total RNA was isolated from interscapular brown and reproductive white adipose tissues using the
RNeasy Lipid Tissue Kit (QIAgen). RNA concentration was measured via Nanodrop and RNA quality/integrity was assessed with a
BioAnalyzer (Agilent). RNaseq libraries were constructed using the RiboZero kit (Illumina) from total RNA samples with RIN scores
> 7.5. Libraries were checked for quality and concentration using the DNA 1000LabChip assay (Agilent) and quantitative PCR, ac-
cording to manufacturer’s protocol. Libraries were sequenced at 2x100 paired end reads on an Illumina HiSeq 4000. After
sequencing, reads were de-multiplexed and assigned to individual samples.
FASTQ files were filtered to remove low quality reads and aligned against LG/J and SM/J custom genomes using STAR (Dobin
et al., 2013; Nikolskiy et al., 2015). Briefly, LG/J and SM/J indels and SNVswere leveraged to construct strain-specific genomes using
the GRC38.72-mm10 reference as a template. This was done by replacing reference bases with alternative LG/J and SM/J bases
using custom python scripts. Ensembl R72 annotations were adjusted for indel-induced indexing differences for both genomes.
Read counts were normalized via upper quartile normalization and a minimum normalized read depth of 10 was required. Alignment
summaries are provided in Figure S4. Library complexity was assessed and differential expression between each age cohort for each
strain-by-diet comparison was determined after TMM normalization in edgeR (Chen et al., 2014).
Functional enrichment of differentially expressed genes was tested by over-representation analysis in the WEB-based Gene Set
Analysis Toolkit v2019 (Zhang et al., 2005). We performed analyses of gene ontologies (biological process, cellular component,
molecular function), pathway (KEGG), and phenotype (Mammalian Phenotype Ontology). For each tissue, the list of all unique differ-
entially expressed genes was analyzed against the background of all unique genes expressed in that tissue (Tables S2 and S3). A
Benjamini-Hochberg FDR-corrected p value % 0.05 was considered significant.
Brown adipose excision
Interscapular brown adipose tissue depots were removed from 20 or 30 week-old high fat-fed SM/J mice. A small longitudinal inci-
sion wasmade between the shoulder blades. All interscapular adipose tissue was carefully removed, and a cauterizing wand used to
stop excessive bleeding when necessary. Surgeries were performed under general anesthesia by IP injection of ketamine/xylazine
(100/200 mg/Kg) and mice were maintained in the surgical plane by isofluorane/oxygen for the duration of the procedure. Incisions
were closed with 5-0 nonabsorbable sutures. Ketoprofen (2 mg/Kg) was provided post-procedure and topical antibiotic was applied
to the incision daily for 3 days. Animal health and well-being was monitored daily. Sutures were removed at 10 days post-surgery.
Mice were allowed to recover for four weeks after surgery or until they reached 30 weeks of age, then underwent a glucose tolerance
test and an insulin tolerance test one week later. After an additional week of recovery, animals were sacrificed and plasma and mul-
tiple tissues harvested (reproductive and inguinal adipose depots, liver, heart, soleus, pancreas, hypothalamus) as described above.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data within individual cohorts were assessed for normality using a Wilks-Shapiro test. Outliers were identified by a Grubbs test (p <
0.05) and removed. The sex X diet X age term was not significant for any phenotype so males and females were pooled for analyses.
For all box-plots, data were tested for significant differences among cohorts by ANOVAwith a Tukey’s post hoc correction. AWelch’s
unequal variances t test was performed between ages in each diet to determine significant differences in adipocyte cell size distri-
bution. Mediation analysis was performed using the ‘mediation’ package in R. P values < 0.05 were considered significant. All sta-
tistical analyses were performed using the R software package.
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Figure S1: Physiological characteriza�on of SM/J and LG/J mice (Related to Figure 1). 
Plasma levels of IGF1 (A), glucagon (B), adiponec�n (C), and lep�n (D) in high and low fat-fed SM/J mice at 20 and 30 weeks. Basal glucose (E) and glucose tolerance (F) of high and low fat-fed SM/J mice 
at 10, 20, 30, 40, and 50 weeks. Insulin tolerance (G) of high and low fat-fed SM/J mice at 20, 30, 40, and 50 weeks. Interscapular brown adipose depot weight in grams (H) and as a percentage of total 
body weight (I) of SM/J mice at 10, 20, 30, 40, and 50 weeks. Body weight (J) and brown adipose �ssue as a propor�on of total body weight (K) in high and low fat-fed LG/J mice at 20 and 30 weeks of 
age. Basal glucose (L) and glucose tolerance (M-N) of high fat-fed LG/J mice are higher than low fat-fed controls at 30 weeks. Insulin sensi�vity (O-P) is not different among the LG/J cohorts.  The 
boxplots display median, 1st and 3rd quar�les, and 1.5*Interquar�le Range for each cohort. Individual data points are also represented. Number of animals per cohort = 8-16 for panels A-D, 21-73 for 
panels E-G, 16-25 for panels H-I, and 30-60 for panels J-P. Approximately equal numbers of males and females represented. Sta�s�cal differences calculated among all cohorts using one-way ANOVA 
with Tukey’s post hoc correc�on. *p<0.05, **p<0.01, ***p<0.0001 
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Figure S2: Morphology and thermogenic characteris�cs of SM/J brown adipose �ssue (Related to Figure 2) 
Quan�fica�on of average cell size (A) and percentage of phosphohistone H3 posi�ve cells (B) in brown adipose depots of high and low fat-fed SM/J mice. Representa�ve images of brown and white adipose from  high fat-fed mice at 20 (C-D) and 30 
weeks of age (E-F)  and from low fat-fed mice at 20 (G-H) and 30 weeks of age (I-J). Stained for H&E (le� picture, scale bar = 200nm) or UCP1 (yellow) and DAPI (blue) (right picture, scale bar = 50nm). Mitochondrial copy number (K) was significantly 
higher in brown adipose �ssue than in inguinal white adipose �ssue at both 20 and 30 week �me points with no significant difference between high or low fat-fed mice. Gene expression levels (L-T) quan�fied in three adipose depots of high fat-fed 
mice: intrascapular brown adipose (iBAT), inguinal white adipose (ingWAT), and reproduc�ve white adipose (repWAT). Canonical brown adipose genes Ucp1 (L), Cidea (M), Eva1 (N), Pgc1a (O), and Prdm16 (P) show high expression in iBAT and no 
difference between 20 and 30 week-old mice. Beige adipose marker Tbx1 (Q) is not expressed in any depot. All adipose depots had roughly equal expression of general adipose markers Adipoq (R), Fabp4/AP2 (S), and Pparg (T). Body temperature (U) 
and plasma free fa�y acid (V), norepinephrine (W) and epinephrine (X) concentra�ons at �me of necropsy. The boxplots display median, 1st and 3rd quar�les, and 1.5*Interquar�le Range for each cohort. Individual data points are also represented. 
Number of animals per cohort = 4 for panels A-B, 6-10 for panels K-T, and 8-21 for panels U-X. Approximately equal numbers of males and females represented. Sta�s�cal differences calculated using one-way ANOVA with Tukey’s post hoc correc�on 
among all cohorts in panels A-B and U-X and between 20 and 30 week cohorts within individual adipose depots for panels K-T.  *p<0.05, **p<0.01, ***p<0.0001 
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C. Figure S3: Addi�onal expression pa�erns of Sfrp1 
(Related to Figure 4). 
Normalized expression for Sfrp1 in brown (A) and white 
(B) adipose of LG/J mice. Correla�on between brown 
adipose Sfrp1 expression and mass in LG/J mice (C). n=8 
animals per cohort. Equal numbers of males and 
females represented. The boxplots display median, 1st 
and 3rd quar�les, and 1.5*Interquar�le Range for each 
cohort. Individual data points are also represented. 
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Figure S4: STAR alignment summaries for RNA-sequencing results 
(Related to STAR Methods) 
Alignment summaries for RNA-sequencing results from (A) SM/J and (B) 
LG/J samples. Brown adipose samples are on the le�, white adipose are 
on the right. Reads per million (le� y-axis) are indicated by bars (yellow = 
uniquely mapped, green = mul� loci, blue = mapped to too many loci) and 
% reads aligned (right x-axis) are indicated by red circles. 
Table S1. High and low fat diet constituents 
Source High Fat# Low Fat*
Energy from Fat 42% 15% 
Casein (g/kg) 195 197 
Sugars (g/kg) 341 307 
Corn starch (g/kg) 150 313 
Cellulose (g/kg) 50 30 
Corn oil (g/kg) --- 58 
Hydrogenated coconut oil (g/kg) --- 7 
Anhydrous milkfat  (g/kg) 210 --- 
Cholesterol (g/kg) 1.5 --- 
Total energy (kJ/g) 18.95 16.99 
# Teklad TD88137 
* Research Diets D12284 
Table S1: High and low fat diet cons�tuents (Related to STAR Methods). The diets (high fat: Teklad 
TD88137; low fat: Research Diets D12284) have been used in mul�ple studies of diet-induced obesity 
using the SM/J strain. 
